+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hyperkalemia Market: A Research Perspective

  • ID: 4985647
  • Report
  • February 2020
  • Region: Global
  • 19 Pages
  • BCC Research
1 of 5

FEATURED COMPANIES

  • Ardelyx
  • Astrazeneca Plc
  • Vifor Pharma
  • MORE

Report Scope:

The current report provides exposure to the hyperkalemia market. This report also highlights current and future market potential along with a detailed analysis of the competitive environment, technological advancements and dynamics such as market drivers and factors restraining market growth. The report also covers market projections through 2022 and includes company profiles. The report details segments such as mild, moderate and severe hyperkalemia. For market estimates, data have been provided for 2018 as the base year, along with 2019 and 2022.

Report Includes:

  • An overview of emerging markets for hyperkalemia
  • A look at the symptoms, available treatment options and briefing about initial investments done for R&D
  • Description of products included, and a detailed analysis of the markets and market opportunities
  • Information on significant products categories, issues and trends, market influences, regulatory issues and other information affecting the industry
  • Brief description of major drivers and regional dynamics of the market and current trends within the industry
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Ardelyx
  • Astrazeneca Plc
  • Vifor Pharma
  • MORE

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Analyst's Credentials

Chapter 2 Summary and Highlights

  • Highlights

Chapter 3 Disease Background and Market Dynamics

  • Disease Background
  • Overview
  • Pathogenesis
  • Diagnosis
  • Epidemiology
  • Treatment
  • Market Dynamics
  • Market Drivers
  • Market Restraints

Chapter 4 Market Breakdown by Severity

  • Mild Hyperkalemia
  • Market Size and Forecast
  • Moderate Hyperkalemia
  • Market Size and Forecast
  • Severe Hyperkalemia
  • Market Size and Forecast

Chapter 5 Company Profiles

  • Ardelyx
  • Astrazeneca Plc
  • Vifor Pharma

List of Tables
Summary Table: Global Hyperkalemia Market, by Severity, Through 2022
Table 1: Global Hyperkalemia Market, Through 2022
Table 2: Global Hyperkalemia Market, by Severity, Through 2022

List of Figures
Summary Figure: Global Hyperkalemia Market Share, by Severity, 2018
Figure 1: Global Hyperkalemia Market Share, by Severity, 2018
Figure 2: Global Mild Hyperkalemia Market, 2018-2022
Figure 3: Global Moderate Hyperkalemia Market, 2018-2022
Figure 4: Global Severe Hyperkalemia Market, 2018-2022

Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Ardelyx
  • Astrazeneca Plc
  • Vifor Pharma
  • MORE

Summary

The goals of this study were to understand the current market scenario for hyperkalemia drugs and to assess the market’s growth potential through the end of 2022.

This study explores market dynamics such as drivers, restraints, opportunities and trends that impact the growth of the market. The main objective of the study is to present a comprehensive analysis of the current market for hyperkalemia and the future direction of the market.

Note: Product cover images may vary from those shown
5 of 5
  • Ardelyx
  • Astrazeneca Plc
  • Vifor Pharma
Note: Product cover images may vary from those shown
Adroll
adroll